Cho NL - Search Results

1

Bidirectional cross talk between patient-derived melanoma and cancer-associated fibroblasts promotes invasion and proliferation.

Izar B, Joyce CE, Goff S, Cho NL, Shah PM, Sharma G, Li J, Ibrahim N, Gold J, Hodi FS, Garraway LA, Novina CD, Bertagnolli MM, Yoon CH. Izar B, et al. Among authors: cho nl. Pigment Cell Melanoma Res. 2016 Nov;29(6):656-668. doi: 10.1111/pcmr.12513. Epub 2016 Sep 22. Pigment Cell Melanoma Res. 2016. PMID: 27482935

2

Changes in antitumor response in C57BL/6J-Min/+ mice during long-term administration of a selective cyclooxygenase-2 inhibitor.

Carothers AM, Moran AE, Cho NL, Redston M, Bertagnolli MM. Carothers AM, et al. Among authors: cho nl. Cancer Res. 2006 Jun 15;66(12):6432-8. doi: 10.1158/0008-5472.CAN-06-0992. Cancer Res. 2006. PMID: 16778222

3

Estrogen receptors alpha and beta are inhibitory modifiers of Apc-dependent tumorigenesis in the proximal colon of Min/+ mice.

Cho NL, Javid SH, Carothers AM, Redston M, Bertagnolli MM. Cho NL, et al. Cancer Res. 2007 Mar 1;67(5):2366-72. doi: 10.1158/0008-5472.CAN-06-3026. Cancer Res. 2007. PMID: 17332369

4

Aberrant crypt foci in the adenoma prevention with celecoxib trial.

Cho NL, Redston M, Zauber AG, Carothers AM, Hornick J, Wilton A, Sontag S, Nishioka N, Giardiello FM, Saltzman JR, Gostout C, Eagle CJ, Hawk ET, Bertagnolli MM. Cho NL, et al. Cancer Prev Res (Phila). 2008 Jun;1(1):21-31. doi: 10.1158/1940-6207.CAPR-07-0011. Epub 2008 Apr 14. Cancer Prev Res (Phila). 2008. PMID: 19138933 Clinical Trial.

5

Immunohistochemical and molecular analysis of tyrosine kinase activity in desmoid tumors.

Cho NL, Carothers AM, Rizvi H, Hasson RM, Redston M, Bertagnolli MM. Cho NL, et al. J Surg Res. 2012 Apr;173(2):320-6. doi: 10.1016/j.jss.2010.10.037. Epub 2010 Nov 26. J Surg Res. 2012. PMID: 21195420

6

Mesenchymal stromal cell mutations and wound healing contribute to the etiology of desmoid tumors.

Carothers AM, Rizvi H, Hasson RM, Heit YI, Davids JS, Bertagnolli MM, Cho NL. Carothers AM, et al. Among authors: cho nl. Cancer Res. 2012 Jan 1;72(1):346-55. doi: 10.1158/0008-5472.CAN-11-2819. Epub 2011 Nov 17. Cancer Res. 2012. PMID: 22094874 Free PMC article.

7

Estrogen receptor α or β loss in the colon of Min/+ mice promotes crypt expansion and impairs TGFβ and HNF3β signaling.

Hasson RM, Briggs A, Carothers AM, Davids JS, Wang J, Javid SH, Cho NL, Bertagnolli MM. Hasson RM, et al. Among authors: cho nl. Carcinogenesis. 2014 Jan;35(1):96-102. doi: 10.1093/carcin/bgt323. Epub 2013 Oct 8. Carcinogenesis. 2014. PMID: 24104551 Free PMC article.

8

Lack of anti-tumor activity with the β-catenin expression inhibitor EZN-3892 in the C57BL/6J Min/+ model of intestinal carcinogenesis.

Hasson RM, Briggs A, Rizvi H, Carothers AM, Davids JS, Bertagnolli MM, Cho NL. Hasson RM, et al. Among authors: cho nl. Biochem Biophys Res Commun. 2014 Feb 14;444(3):283-9. doi: 10.1016/j.bbrc.2013.11.135. Epub 2014 Jan 31. Biochem Biophys Res Commun. 2014. PMID: 24486542

9

Antitumor effects of hyaluronan inhibition in desmoid tumors.

Briggs A, Rosenberg L, Buie JD, Rizvi H, Bertagnolli MM, Cho NL. Briggs A, et al. Among authors: cho nl. Carcinogenesis. 2015 Feb;36(2):272-9. doi: 10.1093/carcin/bgu324. Epub 2015 Jan 2. Carcinogenesis. 2015. PMID: 25556151

10

Sorafenib inhibits proliferation and invasion in desmoid-derived cells by targeting Ras/MEK/ERK and PI3K/Akt/mTOR pathways.

Rosenberg L, Yoon CH, Sharma G, Bertagnolli MM, Cho NL. Rosenberg L, et al. Among authors: cho nl. Carcinogenesis. 2018 May 3;39(5):681-688. doi: 10.1093/carcin/bgy038. Carcinogenesis. 2018. PMID: 29538717

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

76 results

Search Page